CME/CE – Update

Gastroenterology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Unlocking the Value of Biosimilar Therapies in IBD

Unlocking the Value of Biosimilar Therapies in IBD

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s), ABIM MOC Points
In this CME Outfitters webcast, expert faculty will focus on identifying key terminology related to biosimilar products, assessing evidence regarding the efficacy and safety of biosimilars in IBD, and improving patient-provider communication patterns on the topic of biosimilars.
Saturday Morning Coffee with Experts in NASH: What Is The Update?

Saturday Morning Coffee with Experts in NASH: What Is The Update? | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This CME Outfitters enduring material features a renowned panel of experts highlighting the underlying mechanisms of NASH via innovative augmented reality (AR) animations and presenting real-world case scenarios to share clinical insights on how to choose appropriate non-invasive diagnostic modalities, as well as translate latest data on emerging targeted therapies and their implications for clinical practice.
@MondayNightIBD: identifying the Factors that Impact Success in Your Practice

@MondayNightIBD: Factors that Impact Success in Your Practice | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
In this webcast, CME Outfitters and @MondayNightIBD come together to bring you a panel of experts who will tailor a series of patient cases. These cases will focus on the application of cutting-edge data for novel therapies, identifying appropriate treatment strategies for special populations such as young patients and racial/ethnic minorities, and developing patient communication strategies, with the aim of achieving optimal patient outcomes.
Bringing UC Clinical Decision-Making into Focus for 2020: Identify the Right Treatment for the Right Patient at the Right Time

Bringing UC Clinical Decision-Making into Focus for 2020: Identify the Right Treatment for the Right Patient at the Right Time | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
In this CME Outfitters webcast, expert faculty will compare the new AGA and ACG guideline recommendations and discuss recent clinical trial and real-world data in order to provide learners with recommendations on selecting the appropriate therapy for individual patients. In addition, faculty will discuss proven strategies to empower, educate, and engage patients in their UC care.
What's New: Evidence-Based Strategies for Managing CDI

What’s New: Evidence-Based Strategies for Managing CDI | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Provisional, updated Infectious Diseases Society of America (IDSA)/Society for Healthcare Epidemiology of America (SHEA) guidelines were released during ID Week® of 2020 and reflect notable changes in the treatment recommendations of Clostridioides difficile infection (CDI) that are unfamiliar to many clinicians who manage the care of individuals with CDI.
Implementing a Multidisciplinary Approach to Prevention and Diagnosis of CDI

Implementing a Multidisciplinary Approach to Prevention and Diagnosis of CDI | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Accurate diagnosis of Clostridioides difficile infection (CDI) remains an important clinical challenge. In this educational activity, 2 experts provide a comprehensive review of all validated tools and measures for making a definitive diagnosis of CDI, as well as various strategies for preventing the transmission of C difficile.
The Burden of the Disease and Delays in Diagnosis of IBD

The Burden of the Disease and Delays in Diagnosis of IBD | myCME

AMA PRA Category 1 Credit(s)TM
Diagnosing inflammatory bowel disease, and distinguishing between Crohn’s disease and ulcerative colitis, can be challenging for advanced practice providers. This succinct activity reviews common presentations, noninvasive diagnostic tests, and the imaging and endoscopy strategies used to confirm a diagnosis.
Optimizing Management of Patients with IBD

Optimizing Management of Patients with IBD | myCME

AMA PRA Category 1 Credit(s)TM
Recognizing key clinical characteristics of inflammatory bowel disease and distinguishing between Crohn’s disease and ulcerative colitis are crucial prerequisites to developing individually appropriate treatment plans. In this activity, faculty review steps in diagnostic workup and patient assessment, with consideration for the roles that disease activity and disease severity play in choosing or adjusting therapies.
Recurrent CDI: New Options for Prevention and Treatment

Recurrent CDI: New Options for Prevention and Treatment | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
The guideline-recommended, evidence-based prevention and management paradigm of recurrent Clostridioides difficile infection (CDI) has evolved throughout the last several years. This video provides 2 experts’ perspectives on the clinical application of the current and emerging pharmacologic and biotherapeutic strategies for recurrent CDI, with a comprehensible rundown of the latest clinical trials data and a patient case.
Case Challenge: Colic and the Microbiome

Case Challenge: Colic and the Microbiome | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CPEU Credit
While colic is neither dangerous nor harmful, it is a cause of major concern to parents of infants. In this video, two experts discuss the science behind a disordered gut microbiome and the facts about probiotics, particularly Lactobaccillus reuteri, in colic.
The Role of the Gut Microbiome in Infant Health: Real-World Guidance for the Use of Prebiotics and Probiotics to Optimize Neonatal Health and Development

The Role of the Gut Microbiome in Infant Health: Real-World Guidance for the Use of Prebiotics and Probiotics to Optimize Neonatal Health and Development | myCME

AMA PRA Category 1 Credit(s)TM, CPEU Credit, ANCC Contact Hour(s)
Recorded on November 19, 2020, this CME/CE myCME Town Wall activity features lively discussion among experts in the management of at-risk newborns as they explore the latest clinical trial data on the potential utility of prebiotics and probiotics in the NICU, and the implications of recent findings for routine clinical practice.
A Case-Based Approach to the Management of Crohn’s Disease

A Case-Based Approach to the Management of Crohn’s Disease | myCME

AMA PRA Category 1 Credit(s)TM
Participate virtually in the management of Crohn’s disease in a young woman who is experiencing a disease flare 5 years after her initial diagnosis. In this case, clinician and patient collaborate in the process of making management choices that meet the patient’s medical and practical treatment needs.

Click for More Gastroenterology Courses

Next hm-section-front in Gastroenterology CME Courses